The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...
The researchers also found that COPD patients have lower levels of NAD in the blood, which is associated with accelerated aging based on DNA methylation levels. Treatment with vitamin B3 resulted ...
But Dr Sanjay Ramakrishnan, from the University of Oxford, said the work so far "shows massive promise" and that treatment for COPD was "stuck in the 20th Century" despite being one of the leading ...